Pharma channel feed

Mod­er­na notch­es a win in long-run­ning Ar­bu­tus patent fight

3 years ago
Law

Bris­tol My­ers, Foun­da­tion Med­i­cine ex­pand col­lab­o­ra­tion to ex-Turn­ing Point can­cer drug

3 years ago
Deals

How ARPA-H's new hub-and-spoke mod­el will cre­ate a na­tion­wide re­search net­work

3 years ago
R&D

Lat­est ex­ten­sion of Al­ler­gan Aes­thet­ics-spon­sored do­cuseries goes ‘Be­yond the Be­fore & Af­ter’ 

3 years ago
Marketing

Mar­ket­ingRx roundup: Ab­b­Vie, Hori­zon, Mer­ck make cut for 100 best US work­places; Lil­ly taps new chief brand of­fi­cer

3 years ago
Marketing

As­traZeneca launch­es men­tal health hub for blood can­cer pa­tients and care­givers

3 years ago
Marketing

Gilead ad­vances Covid-born on­col­o­gy cam­paign with pa­tient and ad­vo­cate sto­ries

3 years ago
Marketing

Am­gen's Bob Brad­way takes slight salary dip amid high­er pay among US ex­ecs

3 years ago
People

Judge or­ders Mer­ck to hand over ad­verse events data­base in Gar­dasil law­suit

3 years ago
Law

Evotec shuts down IT sys­tems in wake of cy­ber­at­tack

3 years ago

Phar­ma and health­care judges named for Cannes Li­ons ad­ver­tis­ing cre­ativ­i­ty awards

3 years ago
Marketing

Sam­sung and San­doz ques­tion FDA's 're­search roadmap' for biosim­i­lars de­vel­op­ment

3 years ago
FDA+

GSK must pay As­traZeneca roy­al­ties on Ze­ju­la, UK court rules

3 years ago
Law

Wash­ing­ton state stock­piles med­ical abor­tion drug ahead of ex­pect­ed court de­ci­sion

3 years ago

Re­al Chem­istry teams with stock pho­to spe­cial­ist to boost di­verse im­ages in phar­ma mar­ket­ing

3 years ago
Marketing

Con­tract man­u­fac­tur­er Phlow rais­es $36M to build out ser­vices

3 years ago
Financing
Manufacturing

Take­da end­ing dis­cov­ery, pre­clin­i­cal work in AAV gene ther­a­py, rare hema­tol­ogy

3 years ago
People
R&D

Pfiz­er RSV da­ta set up $10B show­down with GSK and Mod­er­na for the next big vac­cine mar­ket

3 years ago
R&D

Rare rheuma­tol­ogy dis­ease in spot­light af­ter Sanofi, Re­gen­eron nab first drug ap­proval, more in pipeline po­ten­tials

3 years ago
Marketing

In­flaRx plans to launch Covid an­ti­body with five-fig­ure price tag

3 years ago
FDA+

Genen­tech notch­es ‘steady progress’ on lat­est di­ver­si­ty and in­clu­sion re­port card

3 years ago
Marketing

Sanofi breaks ground on BAR­DA-backed, $160M vac­cine man­u­fac­tur­ing site in Penn­syl­va­nia

3 years ago
Manufacturing

J&J spin­out files sec­ond bank­rupt­cy at­tempt in $8.9B bid to set­tle talc law­suits

3 years ago
Law

In­flaRx wins FDA emer­gency use au­tho­riza­tion for Covid an­ti­body

3 years ago
FDA+
Coronavirus
First page Previous page 129130131132133134135 Next page Last page
A service from the Financial Times